INS and metabolic syndrome: As expected, participants with MetS had more risk factors than non-MetS controls, including higher BMI, fasting glucose, 2 h plasma glucose, fasting insulin, 2 h serum insulin, HOMA-IR, HbA1c, blood pressure, triglycerides, HDL-c and levels of fat contents (p <0.05 for all participants).